2007
DOI: 10.1016/j.jinorgbio.2006.07.019
|View full text |Cite
|
Sign up to set email alerts
|

Structure and biological properties of the copper(II) complex with the quinolone antibacterial drug N-propyl-norfloxacin and 2,2′-bipyridine

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1
1

Citation Types

6
89
0
8

Year Published

2007
2007
2021
2021

Publication Types

Select...
10

Relationship

0
10

Authors

Journals

citations
Cited by 151 publications
(109 citation statements)
references
References 55 publications
6
89
0
8
Order By: Relevance
“…3a) are maintained in aqueous solution, although the dimeric units of the Cu(II) ternary complex with bpy and N-propyl-norfloxacin in the crystal structure occurs as a mixture of dimeric and monomeric species in aqueous solution. 34) Therefore we can conclude safely that complexes 1, 2 and 3 interact with DNA, and but cannot suggest the exact binding mode of each complex. The precise explanation of the binding modes of the complexes will be confirmed in further studies.…”
Section: Resultsmentioning
confidence: 86%
“…3a) are maintained in aqueous solution, although the dimeric units of the Cu(II) ternary complex with bpy and N-propyl-norfloxacin in the crystal structure occurs as a mixture of dimeric and monomeric species in aqueous solution. 34) Therefore we can conclude safely that complexes 1, 2 and 3 interact with DNA, and but cannot suggest the exact binding mode of each complex. The precise explanation of the binding modes of the complexes will be confirmed in further studies.…”
Section: Resultsmentioning
confidence: 86%
“…The results of the minimum inhibitory concentration (MIC) 43 expressed in µg•mL -1 are listed in Table 3.…”
Section: Antibacterial Activity-minimum Inhibitory Concentrationmentioning
confidence: 99%
“…Cu II Complexes with linear [14] or simple histidine [15] ligands also show good nuclease activity. The recently described complex formed from copper(II), the quinolone antibacterial drug N-propyl-norfloxacin, and 2,2'-bipyridine [16] was reported to bind to calf-thymus DNA (CT-DNA) by the intercalative mode, and exhibited increased antiproliferative and necrotic effects on both HL-60 and K562 human leukemia cells in comparison to free N-propyl-norfloxacin. Further, salen-based Cu II [17] and Schiff-base Cu II [18] complexes were reported to interact with or modify DNA.…”
mentioning
confidence: 99%